Atypical movement disorders in antiphospholipid syndrome

Movement Disorders

Volumn 21, Issue 7, 2006, Pages 944-949

  Martino, Davide ^a,b   Chew, Nee Kong ^a,c   Mir, Pablo ^a,d   Edwards, Mark J ^a   Quinn, Niall P ^a   Bhatia, Kailash P ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BARI   (Italy)

^c UNIVERSITY OF MALAYA   (Malaysia)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

Antiphospholipid syndrome; Corticobasal syndrome; Oral anticoagulation; Tics; Tremor

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CARDIOLIPIN ANTIBODY; CLONAZEPAM; HALOPERIDOL; IMMUNOGLOBULIN G ANTIBODY; LEVODOPA; LUPUS ANTICOAGULANT; STEROID; WARFARIN;

ADOLESCENT; ADULT; ANTICOAGULANT THERAPY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CORTICOBASAL DEGENERATION; DISEASE ASSOCIATION; FEMALE; GENETIC ANALYSIS; HUMAN; INTERNATIONAL NORMALIZED RATIO; MOTOR DYSFUNCTION; MYOCLONUS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; TIC; TREATMENT OUTCOME; TREMOR;

ADOLESCENT; ANTIPHOSPHOLIPID SYNDROME; BRAIN; CEREBRAL INFARCTION; DIAGNOSIS, DIFFERENTIAL; DYSKINESIAS; ELECTROENCEPHALOGRAPHY; ELECTROMYOGRAPHY; FEMALE; FOLLOW-UP STUDIES; FRONTAL LOBE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MOVEMENT DISORDERS; MYOCLONUS; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; OCCIPITAL LOBE; PHENINDIONE; PHENPROCOUMON; SNEDDON SYNDROME; SPINOCEREBELLAR DEGENERATIONS; TICS; TOURETTE SYNDROME; TREMOR; WARFARIN;

EID: 33746879538     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.20842     Document Type: Article

References (28)

1. Sanna G, Bertolaccini ML, Cuadrado MJ, Khamashta MA, Hughes GRV. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 2003;42:200-213.
2. Grossman JM. Primary versus secondary antiphospholipid syndrome: is this lupus or not? Curr Rheumatol Rep 2004;6:445-450.
3. Hughes GRV. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. Br Med J 1983;287:1088-1089.
4. Sanna G, Bertolaccini ML, Cuadrado MJ, et al. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 2003; 30:985-992.
5. Del Papa N, Guidali L, Sala A, et al. Endothelial cells as target for antiphospholipid antibodies: human polyclonal and monoclonal anti-beta 2-glycoprotein I antibodies react in vitro with endothelial cells through adherent beta 2-glycoprotein I and induce endothelial activation. Arthritis Rheum 1997;40:551-561.
6. Sun KH, Liu WT, Tsai CY, Liao TS, Lin WM, Yu CL. Inhibition of astrocyte proliferation and binding to brain tissue of anticardiolipin antibodies purified from lupus serum. Ann Rheum Dis 1992; 51:707-712.
7. Cervera R, Asherson RA, Font J, et al. Chorea in the antiphospholipid syndrome: clinical, radiologic and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 1997;76:203-212.
8. Kiechl-Kohlendorfer U, Ellemunter H, Kiechl S. Chorea as the presenting clinical feature of primary antiphospholipid syndrome in childhood. Neuropediatrics 1999;30:96-98.
9. Milanov I, Bogdanova D. Antiphospholipid syndrome and dystonia-parkinsonism: a case report. Parkinsonism Relat Disord 2001;7:139-141.
10. Angelini L, Zibordi F, Zorzi G, et al. Neurological disorders, other than stroke, associated with antiphospholipid antibodies in childhood. Neuropediatrics 1996;27:149-153.
11. Engelen M, Tijssen MAJ. Paroxysmal non-kinesigenic dyskinesia in antiphospholipid syndrome. Mov Disord 2005;20:111-113.
12. Asherson RA, Khamashta MA, Ordi-Ros J, et al. The "primary" antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366-374.
13. Swedo SE, Leonard HL, Garvey M, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry 1998;155:264-271.
14. Martins da Silva A, Rocha N, Pinto M, et al. Tremor as the first neurological manifestation of Sneddon's syndrome. Mov Disord 2005;20:248-251.
15. Morris HR, Lees AJ. Primary antiphospholipid syndrome presenting as a corticobasal degeneration syndrome. Mov Disord 1999; 14:530-531.
16. Bhatia KP, Lee MS, Rinne JO, et al. Corticobasal degeneration look-alikes. In: Litvan I, Goetz CG, Lang AE, editors. Corticobasal degeneration and related disorders. Philadelphia: Lippincott Williams and Wilkins; 1999. p 169-182.
17. Kleiner-Fisman G, Bergeron C, Lang AE. Presentation of Creutzfeldt-Jakob disease as acute corticobasal degeneration syndrome. Mov Disord 2004;19:948-949.
18. Benito-Leon J, Alvarez-Linera J, Louis ED. Neurosyphilis masquerading as corticobasal degeneration. Mov Disord 2004;19: 1367-1370.
19. Gomez-Puerta JA, Cervera R, Calvo LM, et al. Dementia associated with the antiphospholipid syndrome: clinical and radiological characteristics of 30 patients. Rheumatology (Oxford) 2005;44:95-99.
20. Shi W, Krilis SA, Chong BH, Gordon S, Chesterman CN. Prevalence of lupus anticoagulant and anticardiolipin antibodies in a healthy population. Aust NZ J Med 1990;20:231-236.
21. Vila P, Hernandez MC, Lopez-Fernandez MF, Batlle J. Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects. Thromb Haemost 1994;72:209-213.
22. Vaarala O, Palusuo T, Kleemola M, Aho K. Anticardiolipin response in acute infection. Clin Immunol Immunopathol 1986;41: 8-15.
23. Ziporen L, Polak-Charcon S, Korczyn DA, et al. Neurological dysfunction associated with antiphospholipid syndrome: histopathological brain findings of thrombotic changes in a mouse model. Clin Dev Immunol 2004;11:67-75.
24. Brey RL, Gharavi AE, Lockshin MD. Neurologic complications of antiphospholipid antibodies. Rheum Dis Clin North Am 1993;19: 833-850.
25. Ferreira S, D'Cruz DP, Hughes GR. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand? Rheumatology (Oxford) 2005;44:434-442.
26. Aziz A, Conway MD, Robertson HJ, Espinoza LR, Wilson WA. Acute optic neuropathy and transverse myelopathy in patients with antiphospholipid antibody syndrome: favorable outcome after treatment with anticoagulants and glucocorticoids. Lupus 2000;9: 307-310.
27. Ruiz-Irastorza G, Khamashta MA. Warfarin for multiple sclerosis? Q J Med 2000;93:497-499.
28. D'Cruz DP, Mellor-Pita S, Joven B, et al. Transverse myelitis as the first manifestation of systemic lupus erythematosus or lupus-like disease: good functional outcome and relevance of antiphospholipid antibodies. J Rheumatol 2004;31:280-285.